Glucose Meters in Georgia

SteriLance Medical (USA) Inc., founded in 1993, is a precision medical device manufacturer specializing in diabetes care consumables and clinical blood collection products. The company designs, manufactures, and distributes a comprehensive product portfolio including safety lancets, lancing devices, insulin pen needles, and specialized blood sampling instruments for glucose monitoring. Their product lines serve diabetic self-care and clinical laboratory applications. SteriLance also manufactures surgical blades (disposable safety scalpels) and alcohol preparation pads for clinical and procedural use. The company operates manufacturing facilities in China (Suzhou) with a US operational base in Duluth, Georgia, serving a global distribution network including prominent domestic and international blood glucose meter manufacturers. The company emphasizes user safety, comfort, and functionality in product design. SteriLance maintains quality certifications and regulatory compliance standards appropriate to medical device manufacturing. The firm participates regularly in international medical trade exhibitions (MEDICA, CMEF, Medlab) and maintains active partnerships with leading glucose meter manufacturers worldwide.

MediVena is a medical device manufacturer specializing in blood collection, injection systems, diagnostics, and personal protective equipment (PPE). The company designs and manufactures a comprehensive portfolio of safety-engineered medical consumables under the MEDIVENA ONE-CARE® brand, including safety lancets (PLUS, PRO, OPTI variants), blood collection winged sets (ERGO-SHIELD, GLIDE & LOCK, PRESS & LOCK), safety syringes, pen needles (PRO DUO, DUO, PRO variants), insulin syringes, and blunt fill needles. In diagnostics, MediVena offers glucose monitors (PRO, BGM-100, Smart Glucose Meter for Connected Health), multimeters, and non-contact infrared thermometers. The company also produces oral syringes, enteral syringes, saline flush syringes, and alcohol prep pads for disinfection. MediVena operates with dual headquarters in Atlanta, Georgia (USA) and Warsaw, Poland, serving acute care facilities, long-term care, physician offices, blood banks, home health, and animal health markets across the United States and international territories. The company maintains best-in-class manufacturing capabilities in the US, Europe, Latin America, and Asia, with emphasis on regulatory compliance and operational excellence. MediVena has received support through the Polish Intelligent Development Operational Programme (2014-2020) for R&D projects focused on innovative safe injection needle technology with minimized dead space, completed during 2021-2023.

Rosie Connectivity Solutions is a long-term post-acute care (LTPAC) focused medical equipment and software provider founded in 1977. The company specializes in connected vitals monitoring systems and EHR integration solutions designed to reduce documentation errors, improve nursing workflow efficiency, and enhance patient outcomes in skilled nursing facilities and long-term care environments. Core offerings include the RosieConnectivity platform—a real-time data capture and documentation system that integrates vital signs directly into EHR workflows—and a suite of connected medical devices for point-of-care assessment and monitoring. The company serves skilled nursing facilities, assisted living, and post-acute care providers navigating Medicare/Medicaid reimbursement, infection control requirements, and labor cost pressures. Rosie's product ecosystem addresses common LTPAC pain points: reducing readmissions through continuous vitals monitoring, streamlining compliance documentation, and enabling remote patient assessment capabilities. The platform emphasizes seamless EHR integration to minimize manual data entry and clinical transcription errors. While specific regulatory certifications (FDA 510(k), ISO 13485) are not explicitly stated on the fetched content, the company's focus on connected medical devices and software systems for regulated healthcare environments suggests FDA oversight.

Core Technology Co., Ltd. is a subsidiary of CorDx Union, an international medical diagnostics group established in 2006. The company specializes in in vitro diagnostic (IVD) test kits and point-of-care (POC) testing solutions, serving over 120 countries with more than 1 billion users globally. Product portfolio includes fertility tests, respiratory infectious disease diagnostics, sexual transmitted disease screening, infectious disease panels, cardiac markers, tumor markers, drug-of-abuse screening, and health monitoring tests including blood glucose measurement systems. The company maintains FDA, CE (Conformité Européenne), and NMPA (National Medical Products Administration, China) regulatory certifications for its diagnostic products. Core Technology operates R&D centers, manufacturing facilities, and sales platforms across the United States (California and Georgia headquarters), United Kingdom, Dubai, and Singapore. Manufacturing and quality capabilities are centered in Beijing with industrial facilities exceeding 100,000 square meters. The company participates in major international medical trade shows including Medica, Medlab Asia, and Hospitalar, indicating active engagement in the global clinical diagnostics market.

CorDx Labs is a biotechnology company specializing in in vitro diagnostic (IVD) products for point-of-care and over-the-counter use. With 18+ years of industry experience, CorDx operates a vertically integrated supply chain with manufacturing facilities across the United States and internationally, serving 170+ countries through a global network of 700+ partners. The company manufactures and distributes a portfolio of 1,000+ diagnostic products spanning infectious disease testing (including multiplex rapid tests for flu, COVID-19, and RSV), reproductive and fertility testing, molecular diagnostics, and pet diagnostics. CorDx also offers contract manufacturing services for diagnostic products across multiple therapeutic areas, leveraging advanced quality and compliance systems to ensure operational excellence.